🇺🇸 LLY — Eli Lilly and Company

Healthcare Compra
← Volver

Precio actual

1.149,36 USD

Máx. histórico

1.292,65

16 días

Split 2:1 del 16/10/1997

Caída desde máximo

-11,08%

Rango 52 semanas

712,05 – 1.292,65

Variación hoy

-0,88%

Cierre anterior

1.159,60

Rango de hoy

1.138,31 – 1.158,43

Volumen hoy

2.159.931

Información
Nombre completo
Eli Lilly and Company
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
50.000
PER ⓘ
38,61 (puede no estar actualizado)
Dividend yield
0,60% (puede no estar actualizado)
Precio objetivo analistas
1.315,56 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 4 días
Sobre la empresa

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, such as Cyramza for the second-line treatment of gastric cancer or gastro-esophageal junction adenocarcinoma; Erbitux for colorectal cancers and head and neck cancers; Inluriyo for breast cancer; Jaypirca for chronic lymphocytic leukemia or small lymphocytic lymphoma; Retevmo for the treatment of metastatic NSCLC; TYVYT for classic hodgkin's lymphoma; and Verzenio for breast cancer. In addition, the company offers immunology products, which include Ebglyss for severe atopic dermatitis; Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Omvoh for ulcerative colitis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. Further, it provides Emgality for migraine prevention and episodic cluster headache, as well as Kisubla for symptomatic Alzheimer's disease. The company has collaborations with Boehringer Ingelheim Pharmaceuticals, Inc. for the Jardiance product family; and F. Hoffmann-La Roche Ltd and Genentech, Inc. for lebrikizumab, as well as license agreements with Almirall, S.A. for Ebglyss; and Chugai Pharmaceutical Co., Ltd for orforglipron; strategic collaboration with Ascidian Therapeutics for development of therapies for undisclosed monogenic kidney diseases; and BioArctic AB (publ) for new treatment. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Dividendos repartidos Total últimos 12 meses: 6,6900 USD · Yield: 0,58%
Fecha de pago Importe por participación
14/02/2019 0,6450 USD
14/11/2018 0,5630 USD
14/08/2018 0,5630 USD
16/05/2018 0,5630 USD
14/02/2018 0,5630 USD
14/11/2017 0,5200 USD
11/08/2017 0,5200 USD
11/05/2017 0,5200 USD
13/02/2017 0,5200 USD
10/11/2016 0,5100 USD
11/08/2016 0,5100 USD
11/05/2016 0,5100 USD
10/02/2016 0,5100 USD
10/11/2015 0,5000 USD
12/08/2015 0,5000 USD
Splits Registrados en el histórico de precios
Fecha Ratio
16/10/1997 2:1
21/12/1995 2:1
01/05/1989 2:1
30/01/1986 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
01/07/2004 69,91 70,30 68,23 68,93 -1,40% 2,96% 4.751.000
30/06/2004 70,25 70,73 69,47 69,91 -0,48% 1,79% 5.540.100
29/06/2004 71,60 72,13 69,82 70,25 -2,02% 3,23% 6.256.700
28/06/2004 71,75 72,41 71,51 71,70 +0,42% 1,25% 3.116.100
25/06/2004 72,15 72,20 71,39 71,40 -1,83% 1,12% 4.148.900
24/06/2004 72,65 73,14 72,52 72,73 -0,56% 0,85% 1.435.600
23/06/2004 72,65 73,49 72,10 73,14 +0,29% 1,91% 2.032.300
22/06/2004 72,67 73,20 72,41 72,93 +0,36% 1,09% 2.621.100
21/06/2004 73,30 73,47 72,67 72,67 -1,24% 1,09% 1.842.500
18/06/2004 73,00 74,07 73,00 73,58 +0,05% 1,47% 3.512.800
17/06/2004 72,90 73,69 72,58 73,54 +0,46% 1,52% 1.998.000
16/06/2004 72,80 73,91 72,60 73,20 +0,80% 1,80% 2.072.800
15/06/2004 73,20 73,30 72,40 72,62 -0,11% 1,23% 2.257.300
14/06/2004 73,30 74,05 72,52 72,70 -1,28% 2,09% 2.781.700
10/06/2004 74,00 74,15 73,31 73,64 +0,10% 1,14% 1.700.000
09/06/2004 75,10 75,10 73,46 73,57 -2,40% 2,18% 3.608.900
08/06/2004 75,20 75,65 74,85 75,38 -0,37% 1,06% 1.872.800
07/06/2004 75,65 75,67 74,81 75,66 +0,88% 1,14% 2.056.700
04/06/2004 74,60 75,83 74,50 75,00 +0,86% 1,78% 2.801.200
03/06/2004 74,51 75,40 74,30 74,36 -0,19% 1,48% 2.252.400
02/06/2004 74,95 74,99 74,09 74,50 -0,32% 1,20% 2.447.300
01/06/2004 73,85 74,75 73,67 74,74 +1,45% 1,46% 2.898.100
28/05/2004 73,67 73,95 73,10 73,67 -0,39% 1,15% 2.249.400
27/05/2004 73,95 74,48 73,61 73,96 +0,74% 1,18% 2.397.400
26/05/2004 72,95 73,89 72,75 73,42 +1,87% 1,56% 4.105.800
25/05/2004 70,78 72,24 70,50 72,07 +1,84% 2,46% 3.059.400
24/05/2004 72,10 72,10 70,31 70,77 -1,68% 2,48% 3.351.600
21/05/2004 72,40 72,69 71,50 71,98 -0,46% 1,64% 2.124.700
20/05/2004 72,20 72,56 71,44 72,31 +0,60% 1,55% 2.966.200
19/05/2004 72,70 73,00 71,70 71,88 -0,95% 1,79% 2.757.000